Perioperative management of a patient with hereditary hypoproconvertinemia: 612.116.2:616.151.5
Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)

Keywords

hereditary factor VII deficiency
FVII
hypoproconvertinemia
coagulopathy
cholecystectomy
bleeding

Abstract

Summary. The article presents the experience of perioperative management of a patient with severe congenital factor (F) VII deficiency during laparoscopic cholecystectomy at the First City Clinical Hospital named after E.E.Volosevich (Arkhangelsk). This clinical case demonstrates the choice of the optimal method for perioperative management of a patient with severe congenital FVII deficiency during surgery. The article presents information on the pathophysiology, diagnosis of FVII mutation, an algorithm for diagnosing hereditary coagulopathy — hypoproconvertinemia based on literature data and in real clinical practice, and perioperative management strategy.

For citation: VorobyevaN.A., VorobyevaA.I., VorontsovaA.S., BykovaN.V. Perioperative management of a patient with hereditary hypoproconvertinemia.Tromboz, gemostaz i reologiya. 2025;(2):122–128. (In Russ.).

 References

  1. Peyvandi F., PallaR., Menegatti M. et al.; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinial bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615–21. DOI: 10.1111/j.1538‑7836.2012.04653.x.
  2. Peyvandi F., Di Michele D., Bolton-­Maggs P.H. et al.; Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Classification ofrare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost. 2012;10(9):1938–43. DOI: 10.1111/j.1538‑7836.2012.04844.x.
  3. Clinical guidelines — Rare coagulopathies: hereditary deficiencyof coagulation factors II, VII, X — 2023–2024–2025 (28.04.2023).Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2023.27 рр. (In Russ.). Available at: http://disuria.ru/_ld/12/1292_kr23D68p2MZ.pdf. [Accessed: 15.10.2024].
  4. Alexander B., Goldstein R., Landwehr G., Cook C.D. Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest. 1951;30(6):596–608. DOI: 10.1172/JCI102477.
  5. de Moerloose P., Schved J.-F., Nugent D. Rare coagulation disorders: fibrinogen, factor VII and factor XIII. Haemophilia. 2016;22 Suppl 5:61–5. DOI: 10.1111/hae.12965.
  6. Chevallier P., Bernard J., Bilski-­Pasquier G. et al. Congenital and familial Stuart factor deficiency. Apropos of 2 personal cases considered congenital hypoconvertinemia. Sangre (Barc.). 1959;30:525–35. (In French).
  7. Juraeva N.T., Makhmudova A.D, Madashova A.G Hereditary deficiency of blood coagulation factor VII — hypoproconvertinemia Republican Specialized Scientific and Practical Medical Center of Hematology of the Ministry of Health of the Republic of Uzbekistan. Journal of Community PharmacyPractice. 20228;(22):1–5. DOI: 10.55529/jcpp22.1.5.
  8. Marty S., Barro C., Chatelain B. et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia. 2008;14(3):564–70. DOI: 10.1111/j.1365‑2516.2007.01647.x.
  9. Napolitano M., Siragusa S., Mariani G. Factor VII deficiency: clinical phenotype, genotype and therapy. J Clin Med. 2017;6(4):38. DOI: 10.3390/jcm6040038.
  10. Quintavalle G., Riccardi F., Rivolta G.F. et al.; Ad-­Hoc Study Group. F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study. Thromb Haemost. 2017;117(8):1455–64. DOI: 10.1160/TH17‑02‑0085.
  11. Herrmann F.H., Wulff K., Auberger K. et al. Molecular biology and clinical manifestation of hereditary factor VII deficiency. Semin Thromb Hemost. 2000;26(4):393–400. DOI: 10.1055/s‑2000‑8458.
  12. Robinson K.S. An overview of inherited factor VII deficiency. Transfus Apher Sci. 2019;58(5):569–71. DOI: 10.1016/j.tran‑sci.2019.08.006.
  13. Zabolotskikh I.B., Sinkov S.V., Bulanov A.Yu. et al. Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-­Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology. Vestnik intensivnoj terapii imeni A.I. Saltanova. 2024;(1):7–46. (In Russ). DOI: 10.21320/1818‑474X‑2024‑1‑7‑46.